AcelRx Pharmaceuticals (ACRX) PT Lowered to $2 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray lowered its price target on AcelRx Pharmaceuticals (NASDAQ: ACRX) to $2.00 (from $3.00) while maintaining a Neutral rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
